Oncology ‘Beyond Breakthrough’ Takes Shape: FDA Project Will Create Benefits ‘Menu,’ Rescission Process
• By Kate Rawson
While there is much to like about the program, FDA wants to move away from the idea that Breakthrough is somehow a pre-market “seal of approval” from the agency. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
